U.S. Charges FDA Chemist in $3 Million Inside-Trading SchemeJoshua Gallu and Justin Blum
A U.S. Food and Drug Administration chemist and his son were arrested by federal authorities and accused of reaping at least $3 million from trading on nonpublic information related to drug-approval applications.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
- Goldman Sachs Sees Four 2018 Fed Rate Hikes as U.S. Growth Gains
- Tesla Unveils ‘World’s Fastest Production Car’ and Electric Big Rig
- Norway Idea to Exit Oil Stocks Is ‘Shot Heard Around the World’
- Honda Recalls 800,000 Odyssey Minivans Linked to Injuries
- Why Are Critics Calling the $450 Million Painting Fake?